Home / TORNTPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TORNTPHARM.NS make money? Does TORNTPHARM.NS have pricing power? What's the Earnings Whisper? Will TORNTPHARM.NS profit more as the business scales? What is TORNTPHARM.NS's management track record? Is TORNTPHARM.NS's current price justified?

Torrent Pharmaceuticals Limited

₹4558.9 +$710.50 (+18.46%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹4584.1

Day Range

₹4550.4₹4618.9

Year Range

₹3532.6₹5250

Market Cap

1.73T

AVG Volume

507.15K

Trailing/Forward PE

70.75/48.73

PEG ratio

-20.15

Dividend Yield

0.83%

Next Earnings Date

2026-10-23

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

TORNTPHARM.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	156.15B
26 Q4	138.22B
26 Q3	125.34B
26 Q2	120.45B
26 Q1	116.3B
25 Q4	113.17B
25 Q3	111.03B
25 Q2	110.32B
25 Q1	108.29B
24 Q4	105.62B

Net Income (INR) · TTM

TORNTPHARM.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	21.81B
26 Q4	21.63B
26 Q3	22.72B
26 Q2	21.4B
26 Q1	20.02B
25 Q4	19.11B
25 Q3	18.62B
25 Q2	18.02B
25 Q1	17.35B
24 Q4	16.56B

Operating Income (INR) · TTM

TORNTPHARM.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	36.61B
26 Q4	34.4B
26 Q3	33.55B
26 Q2	31.88B
26 Q1	30.5B
25 Q4	29.26B
25 Q3	28.55B
25 Q2	27.96B
25 Q1	20.55B
24 Q4	19.48B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Torrent Pharmaceuticals Limited

Video analysis: TORNTPHARM.NS

News: TORNTPHARM.NS

Similar companies